checkAd

     149  0 Kommentare EUROAPI to Invest €50 Million at Its Budapest Site to Meet the Growing Demand for Prostaglandins - Seite 2

    Forward-Looking Statements

    Certain information contained in this press release is forward looking and not historical data. These forward-looking statements are based on opinions, projections and current assumptions including, but not limited to, assumptions concerning the Group’s current and future strategy, financial and non-financial future results and the environment in which the Group operates, as well as events, operations, future services or product development and potential. Forward-looking statements are generally identified by the words “expects”, “anticipates”, “believes”, “intends”, “estimates”, “plans” and similar expressions. Forward looking statements and information do not constitute guarantees of future performances, and are subject to known or unknown risks, uncertainties and other factors, a large number of which are difficult to predict and generally outside the control of the Group, which could cause actual results, performances or achievements, or the results of the sector or other events, to differ materially from those described or suggested by these forward-looking statements. These risks and uncertainties include those that are indicated and detailed in Chapter 3 “Risk factors” of the Universal Registration Document approved by the French Financial Markets Authority (Autorité des marchés financiers, AMF) on April 14, 2023, under number R.23-009 and the Amendment to Universal Registration Document approved by the AMF on April 25, 2023 under number R.23-015. These forward-looking statements are given only as of the date of this press release and the Group expressly declines any obligation or commitment to publish updates or corrections of the forward-looking statements included in this press release in order to reflect any change affecting the forecasts or events, conditions or circumstances on which these forward-looking statements are based.

    ______________________________
    1 Compound annual growth rate
    2 Source: EUROAPI Universal Registration Document


    The Euroapi Stock at the time of publication of the news with a raise of +1,24 % to 10,12EUR on Tradegate stock exchange (06. Juni 2023, 17:27 Uhr).
    Seite 2 von 2




    Business Wire (engl.)
    0 Follower
    Autor folgen

    EUROAPI to Invest €50 Million at Its Budapest Site to Meet the Growing Demand for Prostaglandins - Seite 2 Regulatory News: EUROAPI (Paris:EAPI) announces a €50 million capex investment for the installation of a new state-of-the-art production plant at its Budapest site. The project will be focused on the debottlenecking of the current capacity and the …